BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 4, 2009
View Archived Issues
GE-067 discriminates AD subjects from healthy subjects in phase II trial
Read More
CD-200-Fc fusion protein ameliorates Abeta-induced inflammation in vitro and in vivo
Read More
GlaxoSmithKline presents 5-HT2B receptor ligands for the treatment of fibrosis
Read More
M72/AS01E tuberculosis vaccine is safe and immunogenic in HIV-positive adults
Read More
Phase II data suggests safety and efficacy of lenalidomide monotherapy in multiple myeloma
Read More
Bayer Schering Pharma claims Toll-like receptors for treatment of inflammation
Read More
Roche describes MEK kinase inhibitors as oncolytics
Read More
AstraZeneca claims DGAT-1 inhibitors for the treatment of diabetes
Read More
Medicago reports additional results from H1N1 pandemic vaccine animal studies
Read More
Roche presents phase III Lucentis results in patients with retinal vein occlusion
Read More
FDA approves AstraZeneca and Bristol-Myers' Onglyza for type 2 diabetes
Read More
FDA issues complete response letter denying approval of Savient's BLA for Krystexxa
Read More
FDA advisory committee to review Auxilium's BLA for Xiaflex in Dupuytren's contracture
Read More
FDA issues complete response letter denying approval of ALS' NDA for Restanza in CAP
Read More
Lu-AA-21004 reduces anxiety and depression symptoms in MDD patients
Read More
Gabapentin is efficacious in treatment of cannabis dependence and withdrawal
Read More
FDA approves colchicine for acute gout and Mediterranean fever
Read More
FDA approves Genentech's Avastin for metastatic renal cell carcinoma
Read More
FDA lifts partial clinical hold of Icagen's ICA-105665 trial
Read More
Merck Serono requests re-examination of CHMP opinion for Erbitux in NSCLC
Read More
The FDA approves Lipsovir for the early treatment of cold sores
Read More
Purdue and Transcept sign exclusive U.S. license and collaboration agreement for Intermezzo
Read More
Shire reports results from phase III trial of velaglucerase alfa in type 1 Gaucher disease
Read More
Pharmasset reports preliminary results from phase I clinical trial of PSI-7851 in HCV
Read More
Cornerstone closes strategic transaction with Chiesi for Curosurf and issuance of shares
Read More
Organon and Ligand mutually terminate December 2008 collaboration and license agreement
Read More